Index
Module 4 • Quality & Safety
Protocol Development & Quality Improvement
27%
Data Tables
Protocol Development & Quality Improvement
Jaime Robenolt Gray ~3 min read Module 4 of 20
12
/ 44

Protocol Development and Quality Improvement

E.Examples of a Gap Analysis Include:
1

Centers for Disease Control and Prevention (CDC): The Core Elements of Hospital Antibiotic

Stewardship Programs: Antibiotic Stewardship Program Assessment Tool (excerpt) (Appendix 1)

2ADE prevention related to the following medications: Opioids, anticoagulants, aminoglycosides, etc.
3

Intravenous-to-oral conversion of antihypertensives

4

Medication labeling

5

Medication barcoding and scanning

6

Narcotic diversion prevention

7

Sterile admixture services

8

Extemporaneous compounding services

9

Pharmacist activities during a code or rapid response

10Pharmacy patient care models – Evaluating the number of ICU pharmacists to patient ratios based on

workload, documentation requirements

11American Society of Health-System Pharmacists (ASHP) Practice Advancement Initiative (PAI) to

optimize care through pharmacist-provided comprehensive medication management

12ICU liberation practices, including ABCDEF bundle
13Antibiotic streamlining
14Criteria-based antimicrobials and non-antimicrobials for high-cost/misused drugs
15Departmental professional development education
16Institute for Safe Medication Practices (ISMP) Targeted Medication Safety Best Practices for Hospitals

Can be used to assess progress on safety recommendations from ISMP

Can also be used to develop metrics related to implementation status of these best practices.

17The Joint Commission (TJC) Medication Management Standards

Patient Case

2Neuromuscular blocking agents are high alert medications and have led to significant medication errors and

patient harm. You noticed at your new job in the medical ICU when you went to pull rocuronium from the

automated dispensing cabinet that there were no warnings on the pyxis, and it was in an open cubie pocket.

You recalled ISMP having safety alerts and even a best practice regarding the safe storage and handling

of neuromuscular blocking agents. Which is the best example of how to conduct a gap analysis for the safe

handling and storage of neuromuscular blocking agents?

A.Conduct a survey of other institutions to see how they are handling the storage of NMBs and compare

with practice at your new institution.

B.Recommend implementation of storage solutions based on what your previous institution did.
C.Create a table of the ISMP best practice recommendations for the safe storage and handling of NMBs

and compare with the current practice at your new institution.

D.Survey the staff as to what they think the safest storage would be while still being convenient to obtain.
Ψ΄Ψ±Ψ­ Ψ§Ω„ΩΩŠΨ―ΩŠΩˆ Ψ§Ω„ΨͺΨΉΩ„ΩŠΩ…ΩŠ β€” Ω…Ψ²Ψ§Ω…Ω†Ψ© Ω…ΨΉ Ψ§Ω„Ω€ PDF
Ψ¨Ψ―Ψ‘ Ψ§Ω„ΨͺΨ΄ΨΊΩŠΩ„ Ω…Ω†: Ψ§Ω„Ψ―Ω‚ΩŠΩ‚Ψ© 11 فΨͺΨ­ ΨΉΩ„Ω‰ YouTube